Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Sep 21, 2010


Gentel Biosciences last week launched a menu of new APiX Human Tumor Profiling Kits. The kits, which contain tissue-lysate protein arrays and chromogenic-based detection reagents, are suitable for the testing of putative protein biomarkers in over 13 cancer subtypes, according to the firm.

Gentel's kits combine its APiX chromogenic detection technology and Protein Biotechnologies' collection of normal and diseased human tissue for the study of protein expression differences in patient sample sets. Arrays are available to study human breast, colon, female reproductive tract, larynx and skin, liver, lung, prostate and testes, stomach, thyroid, ovary, kidney, bone marrow, and bladder tissues.

Each kit is configured for use with Gentel's Proteomics Multi-System and AthenaQuant analysis software.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.